RecruitingNCT07425574

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

An Observational Study of Natural Disease Progression in Participants With Macular Dystrophies Expressing a Stargardt-type Clinical Presentation


Sponsor

Astellas Pharma Global Development, Inc.

Enrollment

90 participants

Start Date

Feb 20, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular dystrophies, some of the cells in the macula gradually stop working and may die over time. This leads to vision loss in the center of the eye. Side vision (peripheral vision) is mostly unaffected. Stargardt disease (STGD) is a type of macular dystrophy which is caused by 1 faulty gene (ABCA4). Vision loss most typically happens in childhood, but many people do not develop it until they are adults. As well as STGD, there are other macular dystrophies that look very similar to STGD but that are caused by many other different genes. Together, STGD and STGD-like conditions can be called STGD-type macular dystrophies. This is because they look the same clinically and have similar symptoms. Since different genes can cause these conditions, genetic testing is the only way to be sure which specific condition a person has. In this study, researchers want to learn if the disease progresses in a similar way in people with STGD and STGD-like macular dystrophies. People taking part in the study will continue to manage their condition, as agreed with their own doctor. People will visit their clinic every 6 months to have various standard eye tests and imaging. The information collected will include questions about people's wellbeing, general health, medication and supplements taken, and daily activities. Children over 6 years old and adults with STGD-type macular dystrophies may take part in this study. They will be in the study for up to 24 months (2 years). The study sponsor (Astellas) will not decide how people's condition is managed. However, the sponsor will provide instructions on when people visit their clinic and what is recorded during the study. If available, medical records, clinical and imaging data from previous visits going back 24 months will also be reviewed.


Eligibility

Min Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No Intervention for people with stargardt disease, stargardt macular dystrophy, and other related conditions. The study is currently recruiting participants at 12 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention

No investigational drug will be administered to participants in this study.


Locations(15)

Associated Retina Consultants

Phoenix, Arizona, United States

Stanford University School of Medicine

Palo Alto, California, United States

University of California Health - UC Davis

Sacramento, California, United States

University of Florida Health - UF Health Jacksonville

Jacksonville, Florida, United States

University of Miami Health System - Bascom Palmer Eye Institute

Miami, Florida, United States

University of Illinois Chicago - UI Health

Chicago, Illinois, United States

University of Michigan Health - Kellogg Eye Center

Ann Arbor, Michigan, United States

Deep Blue Retina

Southaven, Mississippi, United States

Duke Eye Center

Durham, North Carolina, United States

Cincinnati Eye Institute

Cincinnati, Ohio, United States

Casey Eye Institute - Oregon Health & Science University

Portland, Oregon, United States

Wills Eye Physicians - Mid Atlantic Retina

Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Retina Foundation of the Southwest

Dallas, Texas, United States

University of Utah Health - John A Moran Eye Center

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07425574


Related Trials